LEADER 04132nam  22006495  450 
001 9910369949103321
005 20200707005828.0
010   $a3-030-28646-0
024 7 $a10.1007/978-3-030-28646-0
035   $a(CKB)4100000009678336
035   $a(MiAaPQ)EBC5967910
035   $a(DE-He213)978-3-030-28646-0
035   $a(PPN)269148671
035   $a(EXLCZ)994100000009678336
100   $a20191023d2020      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aManagement of Non-Muscle Invasive Bladder Cancer /$fby Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala
205   $a1st ed. 2020.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020.
215   $a1 online resource (377 pages) $cillustrations
311   $a3-030-28645-2 
320   $aIncludes bibliographical references and index.
327   $aBladder cancer survivorship -- Survivor burdens unmet needs -- CPEX testing in bladder cancer -- Management of low, intermediate and high risk bladder cancer -- Neoadjuvant chemotherapy in muscle invasive bladder cancer -- Multimodal therapy for muscle invasive bladder cancer  -- None Muscle invasive bladder cancer- chemotherapy or resection -- Muscle invasive bladder cancer- open, laparoscopic or roboticG3 NMIBC- BCG versus cystectomy -- Role of immunotherapy in bladder cancer  -- Robotic Surgery and bladder cancer -- Quality of life post Cystectomy -- The Neobladder and Quality of life -- Ileal conduit versus neobladder, which is better? -- Quality of life post NMIBC or BCG -- Rarc technical tips and tricks -- Robotic Surgery and resection -- Robotic radical cystectomy and PLND -- Robotic cystectomy and sentinal node mapping -- Robotic cystectomy and neobladder formation -- Robotic cystectomy and enhanced recovery -- Robotic radical cystectomy, pain and enhanced recovery -- Enhanced recovery and hypoalbumineamia -- The Robotic approach to redo surgery -- Robotic cystectomy and ureteric strictures -- BCG and cystectomy -- BCG and secondary malignancy. .
330   $aThis book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors. Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.
606   $aUrology
606   $aOncology  
606   $aGeriatrics
606   $aOccupational medicine
606   $aUrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H62002
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
606   $aGeriatrics/Gerontology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33150
606   $aOccupational Medicine/Industrial Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H42001
615  0$aUrology.
615  0$aOncology  .
615  0$aGeriatrics.
615  0$aOccupational medicine.
615 14$aUrology.
615 24$aOncology.
615 24$aGeriatrics/Gerontology.
615 24$aOccupational Medicine/Industrial Medicine.
676   $a616.99462
676   $a616.99462
700   $aGoonewardene$b Sanchia S$4aut$4http://id.loc.gov/vocabulary/relators/aut$0787542
702   $aPersad$b Raj$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aMotiwala$b Hanif$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aAlbala$b David$4aut$4http://id.loc.gov/vocabulary/relators/aut
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910369949103321
996   $aManagement of Non-Muscle Invasive Bladder Cancer$92210793
997   $aUNINA